IP Library › Granted Patent US 7,947,843
Granted Patent B2
US 7,947,843 · App. 12/251,879 · Granted May 24, 2011

Crystalline chemotherapeutic

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,947,843
App. No.
12/251,879
Granted
May 24, 2011
Kind
B2
Abstract

N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Hydrate Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed.

Claims (1)

1. N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Hydrate Crystalline Form 1 which, when measured at about 25° C. with radiation at 1.54178 Å, is characterized by a powder diffraction pattern having respective 2θ values of about 6.2°, 12.0°, 12.4°, 12.8°, 13.4°, 14.2°, 15.2°, 15.6°, 16.2° and 19.7°.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030237/0588 →
CORRECTIVE ASSIGNMENT TO CORRECT THE <CONVEYING PARTIES> PREVIOUSLY RECORDED ON REEL 022131 FRAME 0253. ASSIGNOR(S) HEREBY CONFIRMS THE ADD <MICHAEL J. ROZEMA> AND <SHAILENDRA V. BORDAWEKAR> AND <ALEXANDER F. CHU-KUNG>.. Recorded Mar 22, 2011
From: BORCHARDT, THOMAS B.; ROZEMA, MICHAEL J.; BORDAWEKAR, SHAILENDRA V.; CHU-KUNG, ALEXANDER F.
To: ABBOTT LABORATORIES
Reel/Frame 025999/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2009
From: BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 022131/0253 →